Capital Ventures Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Capital Ventures Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $22.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Capital Ventures Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $22.1K Trade | TransData Nexus

Capital Ventures Private Limited

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $22.1K Total Trade · DGFT Verified

Capital Ventures Private Limited is an Indian pharmaceutical exporter with a total trade value of $22.1K across 2 products in 1 therapeutic categories. Based on 42 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Iodex ($13.6K), Volini ($8.5K), .

Capital Ventures Private Limited — Export Portfolio & Destination Treemap

Capital Ventures Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Capital Ventures Private Limited? — Company Overview & Market Position

Capital Ventures Private Limited, established on February 19, 2013, is a private limited company headquartered in New Delhi, India. The company operates under the Corporate Identification Number (CIN) U51909DL2013PTC248485 and is registered with the Registrar of Companies, Delhi. As of the latest available data, Capital Ventures has an authorized capital of ₹14.00 crore and a paid-up capital of ₹10.00 crore. The company employs approximately 96 professionals.

Capital Ventures specializes in the wholesale trading of Fast-Moving Consumer Goods (FMCG), including personal care products, detergents, fabric care products, home care products, groceries, beverages, snacks, and dietary supplements. The company exports over 15,000 products to more than 70 countries, with a significant presence in the Asia-Pacific, North American, and Gulf regions.

What Does Capital Ventures Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Iodex$13.6K 2Volini

Product Portfolio — Top 2 by Export Value

Capital Ventures Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Iodex	Brand Names & OTC Products	$13.6K	18	0.2%	13
2	Volini	Brand Names & OTC Products	$8.5K	24	0.3%	8

Capital Ventures Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $22.1K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Capital Ventures Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

While Capital Ventures Private Limited is primarily engaged in the wholesale trading and distribution of FMCG products, it does not operate its own manufacturing facilities. Instead, the company collaborates with various manufacturers to source a diverse range of products, including personal care items, detergents, fabric care products, home care products, groceries, beverages, snacks, and dietary supplements. This approach allows Capital Ventures to offer a comprehensive product portfolio without the complexities associated with managing manufacturing operations.

3Key Leadership

The leadership team at Capital Ventures Private Limited comprises several key individuals:

Vivek Aggarwal: Managing Director, appointed on April 15, 2024.

Rishab Saggar: Director, serving since September 26, 2017.

Pankaj Kumar Ratra: Whole-Time Director, appointed on January 1, 2021.

Vaneet Aggarwal: Managing Director, appointed on April 15, 2024.

These leaders bring a wealth of experience and strategic vision to the company, guiding its operations and growth initiatives.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Capital Ventures Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Capital Ventures Private Limited's export data indicates a focus on finished pharmaceutical formulations, including products like Iodex and Volini, with a total export value of $22,000 USD across 42 shipments. However, the available information does not specify the company's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, or Japan. Without detailed regulatory filings, approvals, or market access statuses in these regions, a comprehensive analysis of Capital Ventures' operations in these markets cannot be provided.

2Emerging Markets

Capital Ventures Private Limited has a significant presence in emerging markets, exporting over 15,000 products to more than 70 countries, including regions in Africa, Latin America, and Southeast Asia. The company's focus on exporting finished pharmaceutical formulations, such as Iodex and Volini, suggests an interest in expanding its footprint in these markets. While the available data does not confirm WHO prequalification for these products, the company's extensive export activities indicate a strategic approach to penetrating emerging markets.

3Geographic Strategy

Capital Ventures Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

The available data does not provide specific information regarding Capital Ventures Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. Without access to detailed regulatory filings and approvals, a comprehensive assessment of the company's standing with the U.S. Food and Drug Administration (FDA) cannot be conducted.

2WHO & EU GMP

The available information does not confirm whether Capital Ventures Private Limited holds World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certificates. Without access to specific certification details, it is challenging to assess the company's compliance with these international standards.

3CDSCO & Indian Regulatory

Capital Ventures Private Limited operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company's export data indicates that it exports finished pharmaceutical formulations, such as Iodex and Volini. However, without specific information on CDSCO manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs), a detailed analysis of the company's compliance with Indian regulatory requirements cannot be provided.

Capital Ventures Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Capital Ventures Private Limited operates in the FMCG sector, competing with various companies in the wholesale trading and distribution of personal care products, detergents, fabric care products, home care products, groceries, beverages, snacks, and dietary supplements. While specific market share data is not available, the company's extensive export activities to over 70 countries suggest a competitive presence in the global market. A detailed head-to-head analysis would require access to comprehensive market data and competitor profiles.

2Key Differentiators

Capital Ventures Private Limited's key differentiators include its extensive product portfolio, encompassing over 15,000 products across various FMCG categories, and its significant export presence in more than 70 countries. The company's focus on delivering high-quality products, such as its Parliament brand of rice and pulses, underscores its commitment to quality and customer satisfaction.

3Strategic Position

Capital Ventures Private Limited's current strategic direction appears to be centered on the wholesale trading and distribution of FMCG products, with a notable emphasis on exporting finished pharmaceutical formulations. The company's extensive export activities and diverse product offerings suggest a strategy aimed at global market penetration and growth. Future strategic initiatives may include diversifying product lines, enhancing regulatory compliance, and expanding into new markets to sustain and accelerate growth.

Buyer Due Diligence Brief — Evaluating Capital Ventures Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Capital Ventures Private Limited's export data indicates a focus on finished pharmaceutical formulations, including products like Iodex and Volini, with a total export value of $22,000 USD across 42 shipments. However, without detailed information on the company's supplier relationships, manufacturing practices, and quality control measures, a comprehensive assessment of its track record, export volume consistency, and reliability cannot be conducted.

2Certifications to Verify

Importers considering partnerships with Capital Ventures Private Limited should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm that the company's manufacturing facilities are registered with the U.S. Food and Drug Administration. Verification can be done through the FDA's official website.

WHO-GMP Certification: Ensure that the company holds Good Manufacturing Practice certification from the World Health Organization. This can be verified by contacting the WHO or reviewing their official publications.

Frequently Asked Questions — Capital Ventures Private Limited

How many pharmaceutical products does Capital Ventures Private Limited export from India?

Capital Ventures Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Iodex ($13.6K), Volini ($8.5K). Total export value is $22.1K.

What is Capital Ventures Private Limited's total pharmaceutical export value?

Capital Ventures Private Limited's total pharmaceutical export value is $22.1K, based on 42 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Capital Ventures Private Limited cover?

Capital Ventures Private Limited exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Capital Ventures Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.